Remove 2024 Remove Complication Remove Patient-Centered Remove Physicals
article thumbnail

Q&A: Physicians Weigh Improvements in MASLD Treatment Against Gaps in Assessment Strategies

Physician's Weekly

This is a well-done and concise summary of where we are in 2024 in trying to tackle the immense public health problem of MASLD.” Fontana and Gitanjali Srivastava, MD , shared their perspectives with PW about current and potential MASLD treatments and their impacts on patient care. PW: Why was it important to do this study?

article thumbnail

The Mycoplasma Comeback: Why This Atypical Pneumonia is Back – A PEMCurrents Podcast

PEMBlog

Learning Objectives Describe the clinical presentation, epidemiology, and complications of Mycoplasma pneumoniae infections in pediatric patients, including its atypical manifestations. 2024, www.uptodate.com/contents/mycoplasma-pneumoniae-infection-in-children. 2024 Dec;56(1):2386636. Epub 2024 Aug 3.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

Today, we explore four fascinating studies highlighting innovative approaches to reducing medication use and improving patient outcomes. Patients received brochures detailing the risks of gabapentinoids, nonpharmacologic alternatives, and a proposed deprescribing regimen (see here for the brochure ). in the usual care group.

article thumbnail

Urinary Incontinence Revisited: George Kuchel & Alison Huang

GeriPal

Accreditation In support of improving patient care, UCSF Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IT 121
article thumbnail

Surely You Must be Kidding, PTO?!? “No, and Don’t Call Me Shirley!” – The Seemingly Slapstick (But Yet Unfunny) World of Recent Patent Term Extension Decisions (PART 2)

FDA Law

A surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign or other measure that is thought to predict clinical benefit but is not itself a measure of clinical benefit. According to documents in the PTO’s Patent Center, Lilly has not yet filed a response. That did not happen.

Clinic 59
article thumbnail

Anxiety in Late Life and Serious Illness: A Podcast with Alex Gamble and Brianna Williamson

GeriPal

How, though, do we navigate anxiety and help our patients who may end up in the anxiety spiral that becomes so hard to get out of? ABIM MOC credit will be offered to subscribers in November, 2024. So it tends to be future oriented and tends to show up as a physical sensation in our body. I’m having a bodily reaction.

Illness 130
article thumbnail

RCT of Palliative Care for Heart Failure and Lung Disease: David Bekelman and Lyndsay DeGroot

GeriPal

He also found gaps, including very few studies of patients with lung disease, and little impact of trials on quality of life. ABIM MOC credit will be offered to subscribers in November, 2024. Your research is a lot in this patient population, right? The article we discuss today, also published in JAMA , addresses these two gaps.